Understand erythropoiesis, EPO regulation, and RBC destruction mechanisms as tested on ASCP BOC hematology exam.
Chapter 2 โ ERYTHROCYTE PRODUCTION & DESTRUCTION
1 ยท Priority Table & Quick Foundation
| Topic | Priority | Why It’s Tested |
|---|---|---|
| Normoblast sequence & stage identification (N:C, chromatin, nucleoli, cytoplasm color) | HIGH | Cell-ID items: ‘which stage is described?’, last stage that divides, first stage with visible Hb |
| Reticulocyte: stain, count, reference range, polychromasia, shift retics | HIGH | Every anemia work-up; NMB vs Wright confusion; absolute count math |
| Erythropoietin: source, stimulus, target cell, three actions, levels in anemia vs CKD | HIGH | ‘Most EPO-sensitive cell’, ‘EPO in renal anemia’, hypoxia as the real stimulus |
| Extravascular vs intravascular hemolysis & lab markers (Hp, hemoglobinuria, hemosiderinuria, bilirubin) | HIGH | Classic pattern-recognition questions with a hemolysis panel |
| RBC metabolic pathways (EMP, HMP/G6PD, MetHb reductase, Rapoport-Luebering) | HIGH | ‘Which pathwayโฆ?’ questions; G6PD/Heinz bodies; 2,3-BPG and Oโ release |
| Membrane skeleton: spectrin, ankyrin, band 3, 4.1, 4.2 (vertical vs horizontal) | HIGH | Basis for spherocytosis/elliptocytosis questions later in the course |
| Deformability & cation balance (Naโบ/Kโบ-ATPase, Caยฒโบ, ATP loss โ spherocyte) | MEDIUM | Explains senescence and why ATP failure โ hemolysis |
| Membrane lipids: asymmetry, cholesterol exchange, LCAT, echinocyte vs stomatocyte | MEDIUM | Target cells/acanthocytes in liver disease; shape-change questions |
| Apoptosis in erythropoiesis (Fas/FasL, Bcl-XL, JAK2-STAT5) | MEDIUM | Mechanism item: ‘the main way EPO increases RBC mass’ |
| Erythroblastic islands & marrow egress (fibronectin, sinus pores) | MEDIUM | Location questions; ‘what determines timing of egress?’ |
| Erythrokinetics numbers (18โ21 days, 3โ5 divisions, 120-day life span) | MEDIUM | Quick recall numbers |
| Physiologic anemia of newborn, sex and altitude differences | MEDIUM | Reference-interval interpretation questions |
| Nomenclature systems (rubriblast vs erythroblast vs normoblast) | LOW | Matching names only |
| Membrane electrophoresis band numbers beyond the major proteins | LOW | Rarely tested beyond spectrin, ankyrin (2.1), band 3, 4.1, 4.2 |
Focus: the 6 maturation stages with their key features, the reticulocyte, EPO (kidney, hypoxia, CFU-E, blocks apoptosis), the 4 metabolic pathways and what each protects, and the extravascular vs intravascular hemolysis panels. Skim: individual phospholipid names, minor skeletal proteins (adducin, tropomodulin, dematin), and history.
Quick Foundation โ from zero
- The red cell has one real job: carry oxygen from the lungs to the tissues. Everything in this chapter protects that job.
- RBCs are made in the marrow from committed progenitors (BFU-E โ CFU-E), then pass through six visible stages, getting smaller, making hemoglobin, and finally throwing out the nucleus.
- The young, nucleus-free cell still has some RNA โ the reticulocyte. It tells you how hard the marrow is working.
- The kidney senses low oxygen and releases erythropoietin (EPO), which rescues young erythroid cells from programmed death, so more of them survive to become RBCs.
- A mature RBC has no nucleus and no mitochondria โ it cannot repair itself and gets all its energy from glucose by glycolysis.
- Its flexible membrane and skeleton let a 7โ8 ยตm cell squeeze through 3 ยตm gaps in the spleen for about 120 days.
- Old cells are eaten by macrophages (extravascular, ~90%). A small share burst inside vessels (intravascular, ~10%); plasma proteins (haptoglobin, hemopexin) salvage what spills out.
The RBC is a delivery van with no mechanic. It is built in a factory (marrow) that removes the engine shop (nucleus) to make room for cargo (hemoglobin). It runs on one fuel line (glycolysis). When parts wear out, it can’t be repaired โ so the city’s tow service (splenic macrophages) scraps it at ~120 days and recycles the metal (iron) and tires (globin), sending the trash (bilirubin) to the liver.
Every anemia is either too little production (low retic, check EPO/iron/marrow) or too much destruction/loss (high retic + hemolysis markers). This chapter gives you the tools to tell them apart.
| Concept | Plain-English Explanation |
|---|---|
| Erythron vs RBC mass | Erythron = ALL erythroid cells in the body (marrow precursors + circulating + splenic). RBC mass = only circulating cells |
| Normoblast / erythroblast | Nucleated RBC precursor with normal appearance; ‘megaloblast’ = the abnormal large version in B12/folate deficiency |
| N:C ratio | How much of the cell is nucleus vs cytoplasm; falls as the RBC matures (8:1 โ 1:2) |
| Polychromasia | Bluish-gray young RBCs on Wright stain = reticulocytes seen without a supravital stain |
| Shift (stress) reticulocyte | Retic pushed out of the marrow early by high EPO โ large, very blue, no central pallor |
| Apoptosis | Planned cell suicide without inflammation โ the brake that sets how many RBCs are produced |
| Senescence | Aging of the RBC as its enzymes run down; ends in removal by macrophages |
| Hemolysis | RBC destruction โ extravascular (in macrophages) or intravascular (inside vessels) |
2 ยท Core Content Tables
2.1 Erythroid Progenitors (BFU-E โ CFU-E)
| Feature | Details |
|---|---|
| Definition | Committed (unipotent) erythroid progenitors โ not morphologically recognizable; defined by colonies in culture |
| BFU-E | CD34+, high proliferative potential, low cycling; few EPO receptors (EPO-insensitive except at high levels); driven by ‘burst-promoting activity’ = IL-3 / GM-CSF; forms large multifocal ‘burst’ colonies (10โ14 days) |
| CFU-E | Loses CD34, gains glycophorin A, Rh, ABH/Ii antigens; most EPO receptors โ most EPO-sensitive; 3โ5 divisions; cannot survive without EPO |
| Timing | ~1 week BFU-E โ CFU-E; ~1 week CFU-E โ pronormoblast; ~6 days pronormoblast โ circulating retic; total 18โ21 days BFU-E โ RBC |
| Other positive cytokines | SCF, TPO, IL-11 (plus IL-3, GM-CSF, EPO) |
| Negative regulators | TNF-ฮฑ, TGF-ฮฒ, IFN-ฮณ |
Progenitors are defined by behavior, precursors by appearance. The first cell you can see and name is the pronormoblast.
2.2 Normoblast Maturation โ Stage Table
| Stage (normoblastic / rubriblastic) | Size | N:C | Nucleus | Cytoplasm | Divides? | % BM nucleated / Time |
|---|---|---|---|---|---|---|
| Pronormoblast (rubriblast) | 12โ20 ยตm* | 8:1 | Round, fine open chromatin, 1โ2 nucleoli | Dark blue (ribosomes); Golgi halo; may have tufts | Yes | ~1% ยท ~24 h |
| Basophilic normoblast (prorubricyte) | 10โ15 ยตm* | 6:1 | Chromatin begins to condense (‘wheel-spoke’); nucleoli 0โ1, disappear | Deeper, richer blue than pronormoblast; Hb made but masked | Yes | 1โ4% ยท ~24 h |
| Polychromatic normoblast (rubricyte) | 10โ12 ยตm* | 4:1 โ ~1:1 | Coarse clumped chromatin; no nucleoli | Murky gray-blue โ first stage with visible Hb | Last stage that divides (early) | 10โ20% ยท ~30 h |
| Orthochromic normoblast (metarubricyte) | 8โ10 ยตm* | 1:2 | Pyknotic, eccentric, extruded late in stage | Salmon-pink with slight blue tinge | No | 5โ10% ยท ~48 h |
| Polychromatic erythrocyte / Reticulocyte | 8โ10 ยตm | No nucleus | None | Wright: diffusely bluish; NMB: blue reticulum | No | ~1% ยท 1โ2 d marrow + ~1 d blood |
| Erythrocyte | 7โ8 ยตm; 1.5โ2.5 ยตm thick; MCV 80โ100 fL | No nucleus | None | Salmon pink; central pallor โ โ of diameter | No | Circulates ~120 days |
*Sizes and marrow percentages from Rodak; McKenzie lists larger sizes (pronormoblast 20โ25, basophilic 16โ18, polychromatic 12โ15, orthochromic 10โ15 ยตm) and polychromatic normoblasts at 13โ30%. Learn the trend (steady shrinkage, N:C falling) rather than exact micrometers.
| Maturation Trend | Immature โ Mature | Why |
|---|---|---|
| Cell and nuclear diameter | โ (nucleus shrinks faster than cell) | Nuclear condensation โ N:C falls |
| Chromatin | Fine โ coarse, clumped โ pyknotic | Transcription shuts down |
| Nucleoli | Present โ gone | Ribosome production stops |
| Cytoplasm color | Blue โ gray-blue โ salmon pink | RNA (basophilic) falls, Hb (acidophilic/eosinophilic) rises |
| Division | Yes until polychromatic normoblast | Condensed chromatin can’t divide |
One pronormoblast undergoes 3โ5 divisions โ 8โ32 RBCs. The extruded nucleus wrapped in membrane is a pyrenocyte; macrophages eat it by recognizing phosphatidylserine (‘eat me’). Nuclear fragments left behind = Howell-Jolly bodies, normally pitted by the spleen. About 80% of the cell’s hemoglobin is made in the normoblast stages and 20% in the reticulocyte.
2.3 Reticulocyte
| Feature | Details |
|---|---|
| Definition | Anucleate young RBC containing residual ribosomal RNA (and mitochondria); called polychromatic erythrocyte on Wright stain, reticulocyte with a supravital stain |
| Reference range | 0.5โ2.5% of RBCs in adults; absolute โ 18โ158 ร 10โน/L (lab-specific). Newborn: 4โ7%, falling to <1% within a week |
| Stain | Supravital โ new methylene blue (NMB) or brilliant cresyl blue precipitate RNA as a blue mesh/dots. Not visible as a reticulum on Wright stain |
| Mechanism of increase | Blood loss or hemolysis โ hypoxia โ โ EPO โ more precursors survive + early release of shift (stress) retics |
| Mechanism of decrease | Marrow failure, EPO deficiency (CKD), nutrient lack (iron, B12, folate) โ inadequate production |
| Life cycle | ~3 days total: first 1โ2 days in marrow, then ~1 day in blood (longer for shift retics); spleen pits inclusions and ‘polishes’ excess membrane โ biconcave disc |
| Egress | Loses adhesion receptors (fibronectin receptor) โ leaves island โ squeezes through pores in sinus endothelial cells |
| Absolute count | Absolute retic = retic % ร RBC count (e.g., 2% ร 4.0 ร 10ยนยฒ/L = 80 ร 10โน/L) |
| Beyond these two chapters (highly tested) | Corrected retic = retic % ร (patient Hct รท 45); Reticulocyte Production Index = corrected retic รท maturation time (1.0 d at Hct 45, 1.5 at 35, 2.0 at 25, 2.5 at 15). RPI > 2โ3 = adequate marrow response |
| Key pitfalls | Polychromasia on Wright โ increased retics. Punctate basophilia (basophilic stippling) is degenerate RNA in distinct dots on Wright stain โ not the same thing |
- Specimen: EDTA whole blood; follow your analyzer’s validated stability (retic RNA degrades with time โ analyze promptly)
- Manual: equal volumes blood + NMB incubated ~10โ15 min before smearing; count โฅ1,000 RBCs (Miller disc reduces imprecision)
- False โ (manual): Heinz bodies, Howell-Jolly bodies, Pappenheimer bodies, HbH inclusions, stain precipitate โ reticulum is a mesh of two or more blue particles
- False โ (automated): WBC fragments, large platelets, malaria parasites, nucleated RBCs, Howell-Jolly bodies
- Always convert to an absolute count or corrected value in anemia โ the % alone overstates response when the RBC count is low
2.4 Erythropoietin (EPO)
| Feature | Details |
|---|---|
| Definition | Thermostable glycoprotein hormone, ~34 kD; true hormone (endocrine). Terminal sialic acid required for in-vivo activity |
| Tissue source | Peritubular interstitial (fibroblast) cells of the kidney โ 80โ90%; liver <15% in adults (liver is main source in the fetus); small amount from marrow macrophages |
| Stimulus | Tissue hypoxia, not RBC count. Kidney gets ~20% of cardiac output, so it detects falling Oโ delivery early |
| Mechanism of elevation | Hypoxia โ HIF-1 (hypoxia-inducible factor) is no longer degraded โ binds the EPO gene enhancer โ โ transcription. Rise is new synthesis, not release of stores |
| Receptor & signaling | EPO-R homodimer (no intrinsic kinase) โ JAK2 โ STAT5 โ anti-apoptotic Bcl-XL; GATA-1 needed for red cell survival |
| Action 1 โ rescue from apoptosis (MAJOR) | Keeps CFU-E alive; reduces Fas expression on young normoblasts so FasL on older normoblasts can’t kill them |
| Action 2 โ faster maturation | Shortens cell cycle; fewer mitoses; increases RNA/Hb synthesis; marrow transit ~6 days โ <4 days |
| Action 3 โ early release | Widens sinus wall pores and downregulates adhesion receptors โ shift retics (even nRBCs in severe anemia) |
| Normal range | Plasma ~4โ27 mU/mL (Rodak) / 2โ25 IU/L (McKenzie) โ method-specific. Stays constant until Hb falls below ~12 g/dL, then rises steeply |
| Levels in disease | โ in most anemias (highest in pure red cell aplasia) ยท โ in anemia of renal disease ยท โ in hypothyroidism (low Oโ demand) ยท โ with some tumors (renal, cerebellar) โ polycythemia |
| Other stimuli | Testosterone (explains higher adult male Hb โ ~1โ2 g/dL), thyroid, pituitary/growth hormone, adrenal hormones |
| Therapeutic use / abuse | rHuEPO for CKD, chemotherapy, HIV (zidovudine) anemia, pre-autologous donation; illicit ‘blood doping’ โ high viscosity, thrombosis |
| Limits of response | Marrow can raise output 5โ10ร only if iron is available: ~6ร in hemolysis (iron recycled) but usually โค2.5ร in blood loss (iron lost) |
- Immunoassay (e.g., chemiluminescence) on serum or plasma; collect before transfusion or ESA therapy
- Interpret against the hemoglobin โ a ‘normal’ EPO in a severely anemic patient is inappropriately low (think renal disease)
- Urine EPO parallels plasma but is rarely used clinically
2.5 Apoptosis & Erythropoiesis
| Feature | Details |
|---|---|
| Why it exists | It takes 18โ21 days to make an RBC. Instead of storing RBCs, the body overproduces CFU-E and lets extras die โ giving an 8โ10 day head start when demand rises |
| Death signal | Fas (death receptor) on young precursors (pronormoblast, basophilic) + FasL on older normoblasts (polychromatic). Many old cells in marrow โ young cells die โ erythropoiesis slows |
| EPO rescue | EPO โ Fas on young cells and โ Bcl-XL, which stops mitochondrial release of cytochrome c |
| Morphology of apoptosis | Condensed nucleus, nucleolar breakdown, cell shrinkage, membrane blebbing, apoptotic bodies; DNA ladder (multiples of 180โ185 bp); no inflammation (vs necrosis) |
2.6 Bone Marrow Microenvironment for Erythropoiesis
| Feature | Details |
|---|---|
| Erythroblastic island | Central macrophage surrounded by rings of erythroblasts at different stages โ macrophage supplies cytokines, eats extruded nuclei and defective cells (ineffective erythropoiesis) |
| Iron | Delivered by transferrin, not by direct macrophage contact (old ‘suckling pig’ theory abandoned) |
| Anchoring | Stromal cells + adhesive molecules (fibronectin, thrombospondin) + receptors on the erythroblast |
| Egress timing | Determined by maturing cells losing their adhesion receptors โ not by stromal cells or pore timing |
| Route out | Between adventitial cells โ through basement membrane โ through pores in (not between) endothelial cells of the venous sinus |
| Lab note | Islands are fragile and usually disrupted by aspiration; seen intact mainly in core biopsies |
2.7 Erythrocyte Membrane โ Composition & Structure
| Feature | Details |
|---|---|
| Composition | ~52% protein, ~40% lipid, ~8% carbohydrate |
| Lipids | โ equal unesterified cholesterol + phospholipids. Outer leaflet: PC, SM (choline). Inner leaflet: PE, PS, PI (amino). Asymmetry kept by ATP-dependent flippase. Glycolipids (outer) carry ABH, Lewis, P antigens |
| Lipid renewal | Mature RBCs can’t make lipid; exchange with plasma lipoproteins. LCAT deficiency/liver disease โ excess membrane cholesterol โ target cells (proportional โ) or acanthocytes (cholesterol-only โ) |
| Shape and leaflets | Outer leaflet expansion โ echinocytes (crenation) ยท inner leaflet expansion โ stomatocytes |
| Integral proteins | Span the bilayer: band 3 (anion exchanger AE1, >1 million copies, Clโป/HCOโโป exchange, Ii antigens, binds glycolytic enzymes and Heinz bodies), glycophorins (GPA = MN, GPB = Ss/U, GPC = Gerbich; negative charge/zeta potential), Rh, Kell, glucose transporter, pumps, DAF |
| Peripheral (skeleton) proteins | Inner face: spectrin (ฮฑ/ฮฒ heterodimers โ tetramers; ‘spring’), ankyrin (band 2.1), band 4.2, band 4.1, actin, adducin, band 4.9 (dematin), tropomyosin, tropomodulin |
| Vertical attachments | Major: spectrin โ ankyrin โ band 3 (stabilized by 4.2). Secondary: spectrinโactinโ4.1 junctional complex โ glycophorin C |
| Horizontal interactions | Spectrin dimerโdimer (head-to-head tetramers) and spectrinโactinโ4.1 junctions, parallel to the membrane. More dimers = more fragile; more tetramers = more stable |
| Clinical significance | Vertical defects โ lost membrane (microvesicles) โ spherocytes; horizontal defects โ elliptocytes/fragmentation (covered in the membrane-disorders chapter) |
2.8 Deformability & Permeability
| Feature | Details |
|---|---|
| Why deformability matters | A 7โ8 ยตm cell must pass ~3 ยตm splenic slits and marrow sinus pores for 120 days |
| Three determinants | โ Biconcave shape (high surface-to-volume ratio) โก Low cytoplasmic viscosity (Hb ‘solution’, MCHC) โข Membrane viscoelasticity (skeleton) |
| Permeability | Freely permeable to water (aquaporin) and anions (band 3); nearly impermeable to Naโบ, Kโบ, Caยฒโบ. Glucose enters by transporter, no ATP and no insulin needed |
| Cation gradients | RBC Naโบ 5.4โ7 vs plasma 135โ145 mmol/L; RBC Kโบ 98โ106 vs plasma 3.6โ5.0 mmol/L (Kโบ โ 25ร higher inside) |
| Pumps (ATP-dependent) | Naโบ/Kโบ-ATPase: 3 Naโบ out, 2 Kโบ in per ATP. Caยฒโบ-ATPase keeps Caยฒโบ very low; needs Mgยฒโบ |
| Mechanism of failure | โ ATP or โ leak โ Naโบ and water enter faster than Kโบ leaves โ swelling โ sphere โ osmotic lysis or splenic trapping. โ Caยฒโบ โ cross-linked rigid skeleton (irreversibly sickled cells) and Gรกrdos channel Kโบ loss โ dehydration |
2.9 Erythrocyte Metabolism โ Four Pathways
| Pathway | Share / Key Enzyme | Product & Job | What Fails When Deficient |
|---|---|---|---|
| Embden-Meyerhof (glycolysis) | 90โ95% of glucose; hexokinase, PFK, pyruvate kinase (PK) | Net 2 ATP/glucose (anaerobic only โ no mitochondria) โ powers pumps, shape, flippase | PK deficiency โ โ ATP โ rigid cells โ hemolytic anemia (most common glycolytic enzyme defect) |
| Hexose monophosphate shunt | 5โ10%; G6PD (first step), glutathione reductase | NADPH โ keeps glutathione reduced (GSH) โ neutralizes oxidants (HโOโ) | G6PD deficiency โ oxidant stress (drugs e.g. primaquine, infection, fava beans) โ Hb denatures โ Heinz bodies โ spleen bites them out โ hemolysis |
| Methemoglobin reductase | Off glycolysis; MetHb reductase (NADH-cytochrome b5 reductase / diaphorase) | Uses NADH to reduce Feยณโบ (MetHb) โ Feยฒโบ (functional Hb) | ~2% MetHb forms daily; without the enzyme it builds to 20โ40% โ โ Oโ capacity โ cyanosis |
| Rapoport-Luebering shunt | BPG mutase / synthase (sacrifices 1 ATP step) | 2,3-BPG โ lowers HbโOโ affinity โ โ Oโ release to tissues | Deficiency โ โ Oโ affinity โ tissue hypoxia (compensatory erythrocytosis); โ activity at altitude and in anemia |
Energy = glycolysis (ATP) ยท Protection from oxidants = HMP (NADPH/GSH) ยท Keeping iron ferrous = MetHb reductase (NADH) ยท Oxygen release = Rapoport-Luebering (2,3-BPG).
- G6PD / PK assays: EDTA or heparin whole blood. Test when the patient is not in active hemolysis and not recently transfused โ young cells and retics have higher enzyme activity and can give a falsely normal result
- Heinz bodies: supravital stain (crystal violet, brilliant cresyl blue); not visible on Wright stain
- Methemoglobin: co-oximetry on fresh arterial or venous blood; MetHb continues to change on standing
2.10 Senescence โ Why RBCs Die at ~120 Days
| Feature | Details |
|---|---|
| Root cause | No nucleus โ no new protein. Glycolytic and antioxidant enzymes decline and can’t be replaced |
| Mechanism | โ ATP โ pumps fail โ Naโบ/water in โ cell becomes spherical and rigid; oxidized membrane lipids/proteins; membrane lost โ โ surface-to-volume |
| Where trapped | Spleen red pulp: sluggish flow, low glucose, low pH, hypoxic โ the ‘splenic sieve’ of sinus endothelium + basement membrane |
| ‘Eat me’ signals | Phosphatidylserine flipped to the outer leaflet, IgG binding to clustered band 3, loss of cation balance, CD47 change (binds thrombospondin-1). Aging is called eryptosis (‘apoptosis in slow motion’) |
| Daily turnover | ~1% of RBCs replaced per day |
2.11 Extravascular vs Intravascular Hemolysis
| Feature | Extravascular (macrophage-mediated) | Intravascular (fragmentation) |
|---|---|---|
| Share of normal destruction | ~90% โ the normal, preferred route | ~10% |
| Where | Macrophages of spleen, liver, bone marrow | Inside blood vessels (turbulence, bifurcations, clots, heart chambers) |
| What happens to Hb | Inside macrophage: Hb โ heme + globin. Globin โ amino acid pool. Heme โ iron (ferritin/hemosiderin or transferrin โ marrow) + CO (exhaled) + biliverdin โ bilirubin | Free Hb in plasma โ ฮฑฮฒ dimers โ bound by haptoglobin (1:1) โ liver. Excess โ kidney โ hemoglobinuria; tubular iron โ hemosiderinuria. Oxidized heme โ hemopexin โ then methemalbumin |
| Bilirubin | โ unconjugated (indirect) | โ unconjugated (liver still processes Hp-Hb) |
| Haptoglobin | Normal to โ (โ in brisk extravascular hemolysis too) | Markedly โ / absent |
| Plasma free Hb | Normal | โ (pink/red plasma) |
| Urine | โ urobilinogen; no Hb | Hemoglobinuria (acute) ยท hemosiderinuria (days later) ยท โ urobilinogen |
| Smear | Spherocytes common | Schistocytes common (mechanical) |
2.12 Hemoglobin Scavenging Proteins
| Feature | Details |
|---|---|
| Haptoglobin (Hp) | ฮฑ2-globulin from liver; binds Hb ฮฑฮฒ dimers 1:1; Hp-Hb too big to filter; cleared in 10โ30 min (Tยฝ). Ref โ 35โ165 mg/dL (lab-specific). Depleted fast because liver can’t keep up |
| Haptoglobin pitfall | Acute-phase reactant โ inflammation, infection, cancer can keep it normal despite hemolysis; liver disease lowers it without hemolysis |
| Hemopexin | ฮฒ-globulin from liver; binds free heme 1:1; Tยฝ 7โ8 hours; used after Hp is depleted |
| Methemalbumin | Oxidized heme + albumin when hemopexin is exhausted โ temporary heme carrier; brown plasma; detected by Schumm’s test |
| Hemosiderinuria | Iron-laden tubular cells shed into urine; Prussian blue stain; sign of recent/chronic intravascular hemolysis |
| Bilirubin pathway | Unconjugated bilirubin + albumin โ liver (UDP-glucuronyltransferase) โ conjugated (direct) โ bile โ gut bacteria โ urobilinogen โ stool (stercobilin); 10โ20% reabsorbed โ urine urobilinogen |
- In-vitro hemolysis (traumatic draw, small needle, forceful transfer) raises plasma free Hb and potassium and interferes with bilirubin โ recollect before calling intravascular hemolysis
- Haptoglobin: serum; interpret with CRP (acute phase) and liver function in mind
- Bilirubin: protect from light (photodegradation falsely lowers results); hemolyzed specimens interfere with many methods
- Urine hemosiderin: urine sediment stained with Prussian blue; appears several days after the hemolytic event and persists โ a negative test the day of an acute event does not exclude it
2.13 Erythrocyte Concentration โ Normal Variation
| Feature | Details |
|---|---|
| At birth | RBC ~5.2 ร 10ยนยฒ/L, Hb ~19 g/dL; retic 4โ7% (high fetal EPO from the hypoxic uterine environment + high-affinity Hb F) |
| Physiologic anemia of the newborn | After birth Oโ saturation rises 45% โ 95% โ EPO becomes undetectable โ marrow pauses โ Hb falls to ~10โ11 g/dL (RBC ~3.5) by 2โ3 months, then EPO restarts |
| Sex | Adult males higher after puberty โ testosterone stimulates EPO and progenitors; no sex difference in children |
| Altitude | Lower atmospheric Oโ โ โ EPO โ higher RBC count (physiologic erythrocytosis); also โ 2,3-BPG |
3 ยท Visual Memory Hooks
โPro Baseball Players Often Run Everywhereโ โ Pronormoblast ยท Basophilic ยท Polychromatic ยท Orthochromic ยท Reticulocyte ยท Erythrocyte.
8 โ 6 โ 4 โ ยฝ โ pronormoblast 8:1, basophilic 6:1, polychromatic 4:1 (โ1:1), orthochromic 1:2.
โBlue โ Bluer โ Muddy โ Pinkโ โ pronormoblast blue, basophilic deeper blue, polychromatic muddy gray-blue, orthochromic salmon.
โPoly is the last to multiplyโ โ polychromatic normoblast = last mitosis AND first visible Hb.
โNMB sees the Net; Wright sees the Tintโ โ new methylene blue shows the reticulum; Wright shows only a bluish tint (polychromasia).
โSAFE Releaseโ โ Survival (anti-apoptosis โ major) ยท Accelerated maturation ยท Fewer divisions ยท Early Release of shift retics.
โKidneys Hate Hypoxiaโ โ Kidney peritubular cells respond to Hypoxia via HIF-1.
โOld cells hold the Lighter (FasL), young cells are the Fuse (Fas)โ โ older normoblasts kill younger ones unless EPO removes the fuse.
โEnergy, Protection, Iron, Oxygenโ = EMP, HMP, MetHb reductase, R-L shunt โ ATP ยท NADPH ยท NADH ยท 2,3-BPG.
โCholine on the Outside, Amino on the Insideโ โ PC, SM outer; PE, PS, PI inner. PS out = ‘eat me’.
โEcho goes Out, Stoma goes Inโ โ outer leaflet expansion = echinocyte; inner leaflet expansion = stomatocyte.
โSpectrin Asks Band 3 For a hugโ โ SpectrinโAnkyrinโBand 3 (+4.2) = vertical; loss โ spherocytes.
โEXTRA = EATEN, INTRA = IN the vesselโ โ extravascular = macrophages (90%); intravascular = burst in vessels (10%).
โHp Hurries, Hemopexin Holds, Albumin is Lastโ โ haptoglobin first (minutes), hemopexin (hours), methemalbumin when both are used up.
Pattern Triggers
| If you seeโฆ | Thinkโฆ | Becauseโฆ |
|---|---|---|
| โ retic + โ haptoglobin + โ indirect bilirubin | Hemolysis | Marrow compensates for cells being destroyed; Hp mops up Hb; heme โ bilirubin |
| Above + hemoglobinuria / pink plasma / hemosiderinuria | Intravascular hemolysis | Hb exceeded haptoglobin and was filtered by the kidney |
| Spherocytes + โ retic + normal-to-low Hp, no hemoglobinuria | Extravascular hemolysis | Macrophages destroy cells; free Hb never reaches plasma |
| Anemia + low retic + low EPO + โ creatinine | Anemia of chronic kidney disease | Peritubular EPO-producing cells lost |
| Hemolysis after primaquine, sulfa or fava beans; Heinz bodies, bite cells | G6PD deficiency | No NADPH โ GSH can’t protect Hb from oxidants |
| Cyanosis with normal PaOโ, chocolate-brown blood | Methemoglobinemia (โ MetHb reductase or oxidant drug) | Feยณโบ Hb can’t carry Oโ |
| Large, very blue RBCs without central pallor in a bleeding patient | Shift (stress) reticulocytes | High EPO released retics 1โ2 days early |
| Nucleated RBCs in blood of a severely anemic adult | Extreme EPO drive or marrow infiltration | EPO can push even normoblasts out early |
| Target cells / acanthocytes in liver disease | Membrane cholesterol excess (โ LCAT) | Free cholesterol loads into the RBC membrane |
| Hemolysis with normal haptoglobin in a febrile, infected patient | Hp raised as acute-phase reactant | False reassurance โ look at other markers |
| Infant Hb 16 โ 11 g/dL at 2 months, well baby | Physiologic anemia of newborn | EPO switched off after birth |
Commonly Confused Pairs
| Feature | A | B |
|---|---|---|
| Erythron vs RBC mass | All erythroid cells (marrow + blood + spleen) | Circulating RBCs only โ a pronormoblast is in the erythron but NOT the RBC mass |
| Polychromasia vs basophilic stippling | Diffuse bluish tint (retics) on Wright | Distinct blue dots of degenerate RNA on Wright (lead poisoning, thalassemia) |
| Reticulocyte vs Heinz body (on NMB) | Blue mesh/network of RNA | Round denatured-Hb inclusions near the membrane |
| BFU-E vs CFU-E | CD34+, few EPO-R, IL-3/GM-CSF driven | CD34โ, many EPO-R, EPO-dependent |
| Apoptosis vs necrosis | Planned, shrinkage, no inflammation | Injury, swelling, lysis, inflammation |
| Haptoglobin vs hemopexin | Binds Hb dimers; ฮฑ2-globulin; Tยฝ minutes | Binds heme; ฮฒ-globulin; Tยฝ 7โ8 h |
| Hemoglobinuria vs hemosiderinuria | Acute โ free Hb spills into urine | Days later โ iron in shed tubular cells (Prussian blue) |
| Integral vs peripheral proteins | Span bilayer (band 3, glycophorins); carry antigens | Inner surface skeleton (spectrin, ankyrin, 4.1, 4.2) |
| NADPH vs NADH | HMP shunt โ glutathione โ oxidant protection | Glycolysis โ MetHb reductase โ iron stays Feยฒโบ |
| Hypoxia vs low RBC count | The actual EPO stimulus | Only one of many causes of hypoxia (lung/heart disease, abnormal Hb also) |
Diagnostic Window / Timeline Table
| Marker / Event | Onset | Peak | Duration | Best Clinical Use |
|---|---|---|---|---|
| EPO rise after hypoxia | Hours (new transcription via HIF-1) | Proportional to hypoxia | While hypoxia lasts | Separates renal (low) from other anemias (high) |
| Reticulocyte response to bleed/hemolysis | ~3โ5 days* | ~7โ10 days* | Until Hb recovers | Proof of adequate marrow response |
| Shift reticulocytes | 1โ2 days after strong EPO stimulus | โ | Circulate ~2โ3 days as retics | Explains polychromasia and RPI correction |
| Plasma free Hb / hemoglobinuria | Immediately | Hours | Clears once Hp/renal handling catches up | Acute intravascular hemolysis |
| Haptoglobin fall | Hours (Hp-Hb Tยฝ 10โ30 min) | Absent in brisk hemolysis | Recovers over days after hemolysis stops* | Most sensitive hemolysis marker (watch acute phase) |
| Hemopexin-heme clearance | Hours | โ | Tยฝ 7โ8 h | Supports Hp depletion |
| Hemosiderinuria | ~3โ4 days after onset* | โ | Persists weeks | Chronic or recent intravascular hemolysis |
| Indirect bilirubin | Hoursโ1 day | Days | While hemolysis continues | Increased heme catabolism |
| BFU-E โ RBC production | โ | โ | 18โ21 days total; precursors ~6 days (โ to <4 days with EPO) | Why anemia response lags |
| RBC life span | โ | โ | ~120 days (100โ120) | ~1% replaced daily |
| Newborn retic | 4โ7% at birth | โ | <1% by ~1 week until month 2 | Physiologic anemia of newborn |
*Typical values from general hematology practice, not stated in these two chapters.
4 ยท Diagnostic Flowcharts
Flowchart 1 โ Anemia: production problem or destruction/loss?
| Adult with โ Hb | โ | Order reticulocyte count; convert to absolute/corrected (RPI) |
| Retic low / inappropriate (RPI < 2) | โ | Hypoproliferative โ check EPO, iron, B12/folate, creatinine, marrow |
| Low retic + low EPO + โ creatinine | โ | Anemia of CKD (EPO deficiency) |
| Retic high (RPI > 2โ3), no bleeding history | โ | Hemolysis โ go to Flowchart 2 |
| Retic high + recent bleeding | โ | Acute blood loss with appropriate marrow response |
| โ ๏ธ Common mistake: reading a ‘high’ retic % in a severely anemic patient as a strong response. When the RBC count is low, the % inflates โ correct it first. | ||
Flowchart 2 โ Hemolysis: extravascular or intravascular?
| โ Retic, โ indirect bilirubin, โ haptoglobin | โ | Hemolysis confirmed โ now check plasma and urine |
| Pink/red plasma, โ plasma free Hb, hemoglobinuria | โ | Acute intravascular hemolysis |
| Hemosiderinuria (Prussian blue urine sediment) | โ | Recent or chronic intravascular hemolysis |
| No free Hb, no hemoglobinuria, spherocytes on smear | โ | Extravascular (macrophage-mediated) |
| Haptoglobin normal but other markers positive + fever/CRP high | โ | Hemolysis likely โ Hp raised by acute phase |
| โ ๏ธ Common mistake: assuming a low haptoglobin always means intravascular hemolysis. Brisk extravascular hemolysis and liver disease also lower it; the urine and plasma separate them. | ||
Flowchart 3 โ Timing: what will the lab show after a bleed?
| Healthy patient loses 1,500 mL at surgery, no transfusion | โ | Day 0: Hb may look near normal (plasma not yet re-expanded) |
| Hours โ day 1โ3 | โ | Hypoxia โ โ EPO (first and most predictable change); Hb falls as plasma volume restores |
| Days 3โ5 | โ | Reticulocytes rising; polychromasia on smear |
| Days 7โ10 | โ | Retic peak; iron supply limits output (~2.5ร normal) because iron was lost |
| Bilirubin / haptoglobin | โ | Expected to stay normal โ no RBC destruction |
| โ ๏ธ Common mistake: expecting โ bilirubin or โ haptoglobin after blood loss. Those are destruction markers; bleeding removes cells without breaking them down in the body. | ||
Flowchart 4 โ Method selection for a young RBC or inclusion
| Need to count reticulocytes | โ | Supravital NMB smear (manual, Miller disc) or automated RNA-dye flow cytometry |
| Only a Wright smear available | โ | Report polychromasia (semi-quantitative), not a retic count |
| Suspect Heinz bodies (oxidant hemolysis) | โ | Supravital crystal violet / brilliant cresyl blue โ not Wright |
| Suspect iron granules (Pappenheimer) | โ | Prussian blue stain โ siderocytes / sideroblasts |
| Suspect methemoglobin | โ | Co-oximetry on fresh blood |
| โ ๏ธ Common mistake: calling bluish cells on a Wright smear ‘reticulocytes’ and giving a %, or trying to find Heinz bodies on a Wright stain. | ||
Flowchart 5 โ Oxidant hemolysis work-up (G6PD pattern)
| Young man, fever and dark urine days after starting primaquine/sulfa or eating fava beans | โ | Suspect oxidant hemolysis |
| Smear: bite cells, blister cells; supravital: Heinz bodies | โ | Hb denatured by oxidants (HMP failure) |
| Labs: โ Hp, โ indirect bilirubin, hemoglobinuria | โ | Intravascular + extravascular components |
| G6PD fluorescent spot test positive (no fluorescence) | โ | G6PD deficiency |
| G6PD normal during the crisis but strong clinical suspicion | โ | Repeat 2โ3 months after recovery |
| โ ๏ธ Common mistake: testing G6PD during acute hemolysis. The old, deficient cells were destroyed; retics have more enzyme, so the result can be falsely normal. | ||
5 ยท 25 High-Yield Facts
| # | Fact |
|---|---|
| 1 | BFU-E and CFU-E are committed erythroid progenitors that cannot be identified morphologically. |
| 2 | The CFU-E has the most EPO receptors and cannot survive without EPO. |
| 3 | It takes 18โ21 days to produce an RBC from a BFU-E, including about 6 days as recognizable precursors. |
| 4 | The maturation order is pronormoblast, basophilic, polychromatic, orthochromic normoblast, reticulocyte, erythrocyte. |
| 5 | The pronormoblast has an N:C ratio of about 8:1, dark blue cytoplasm, and 1โ2 nucleoli. |
| 6 | The basophilic normoblast has a deeper blue cytoplasm than the pronormoblast. |
| 7 | The polychromatic normoblast is the last stage capable of mitosis and the first with visible hemoglobin. |
| 8 | The orthochromic normoblast has a pyknotic nucleus, an N:C ratio of about 1:2, and cannot divide. |
| 9 | One pronormoblast produces 8โ32 RBCs through 3โ5 divisions. |
| 10 | The extruded nucleus (pyrenocyte) is ingested by marrow macrophages that recognize phosphatidylserine. |
| 11 | The adult reticulocyte reference range is about 0.5โ2.5%; newborns have 4โ7%. |
| 12 | Reticulocytes are identified with supravital stains such as new methylene blue. |
| 13 | Reticulocytes spend 1โ2 days in the marrow and about 1 day in the peripheral blood. |
| 14 | EPO is made mainly by peritubular interstitial cells of the kidney in response to hypoxia via HIF-1. |
| 15 | The main way EPO increases RBC production is by preventing apoptosis of erythroid progenitors. |
| 16 | EPO signals through JAK2 and STAT5 to induce the anti-apoptotic protein Bcl-XL. |
| 17 | EPO is increased in most anemias but decreased in the anemia of renal disease. |
| 18 | Erythroblastic islands consist of a central macrophage surrounded by developing erythroblasts. |
| 19 | RBCs leave the marrow when they lose adhesion receptors, such as for fibronectin, and pass through pores in sinus endothelial cells. |
| 20 | The mature RBC is a 7โ8 ยตm biconcave disc with a life span of about 120 days. |
| 21 | Glycolysis supplies 90โ95% of RBC energy, with a net of 2 ATP per glucose. |
| 22 | The HMP shunt, starting with G6PD, generates NADPH to keep glutathione reduced. |
| 23 | The Rapoport-Luebering shunt produces 2,3-BPG, which increases oxygen release to tissues. |
| 24 | About 90% of normal RBC destruction is extravascular in splenic macrophages; about 10% is intravascular. |
| 25 | In intravascular hemolysis, haptoglobin falls, and hemoglobinuria and later hemosiderinuria appear. |
Retic + hemolysis panel: โ retic, โ indirect bilirubin, โ haptoglobin = hemolysis. Add hemoglobinuria / hemosiderinuria / โ plasma Hb = intravascular. Missing those with spherocytes = extravascular. Low retic with low EPO = kidney.
Quick Interpretation Table
| Lab Finding | Clinical Interpretation |
|---|---|
| โ Retic, โ indirect bilirubin, โ Hp, hemoglobinuria | Acute intravascular hemolysis |
| โ Retic, โ indirect bilirubin, spherocytes, no hemoglobinuria | Extravascular hemolysis |
| Hemosiderinuria with mild anemia | Chronic intravascular hemolysis |
| Anemia, โ retic, โ EPO, โ creatinine | Anemia of chronic kidney disease |
| Anemia, โโ EPO, absent retics | Pure red cell aplasia / marrow failure |
| Heinz bodies after oxidant drug | G6PD deficiency (HMP shunt failure) |
| Cyanosis + โ MetHb | MetHb reductase deficiency or oxidant exposure |
| Polychromasia 3+ on Wright smear | Increased (shift) reticulocytes โ marrow responding |
๐ด Flashcards โ Active Recall Practice
๐ Practice Quiz โ Test Your Knowledge
๐ชค Trap Questions โ Beat the Examiner
8 ยท Rapid Revision Sheet
Stage Numbers
- Pro 8:1 ยท Baso 6:1 ยท Poly 4:1โ1:1 ยท Ortho 1:2
- Nucleoli: pro 1โ2 only
- Last division + first Hb: POLY
- Nucleus out: ORTHO
- 1 pro โ 8โ32 RBCs (3โ5 divisions)
Time Numbers
- BFU-E โ RBC 18โ21 d
- Precursors ~6 d (<4 d on EPO)
- Retic 1โ2 d marrow + ~1 d blood
- RBC life 120 d ยท ~1%/day
- Hp-Hb Tยฝ 10โ30 min ยท Hemopexin 7โ8 h
Reticulocyte
- Adult 0.5โ2.5% ยท newborn 4โ7%
- NMB = reticulum ยท Wright = polychromasia
- Absolute = % ร RBC
- Shift retic = big, blue, no pallor
- Heinz/HJ/Pappenheimer โ false โ
EPO
- Kidney peritubular 80โ90% ยท liver <15%
- Hypoxia โ HIF-1 โ EPO gene
- Target: CFU-E (max EPO-R)
- JAK2 โ STAT5 โ Bcl-XL
- โ most anemias ยท โ renal anemia
- Rises when Hb < ~12 g/dL
Metabolism
- EMP 90โ95% ยท 2 ATP ยท PK
- HMP 5โ10% ยท G6PD ยท NADPH/GSH
- MetHb reductase ยท NADH ยท Feยฒโบ
- R-L shunt ยท 2,3-BPG ยท โ Oโ affinity
- G6PD โ Heinz ยท MetHb โ cyanosis
Membrane
- 52% protein ยท 40% lipid ยท 8% CHO
- Outer PC/SM ยท inner PE/PS/PI
- Vertical: spectrinโankyrinโband 3 (+4.2)
- Horizontal: spectrinโactinโ4.1
- GPA = MN ยท GPB = Ss ยท GPC = Gerbich
- Naโบ/Kโบ pump: 3 out / 2 in
Extravascular vs Intravascular
- Extra 90% ยท Intra 10%
- Extra: spherocytes, no Hb in urine
- Intra: โ plasma Hb, hemoglobinuria, hemosiderinuria
- Both: โ indirect bili, โ Hp
- Intra: schistocytes
Opposites
- Outer leaflet โ โ echinocyte ยท inner โ โ stomatocyte
- Blood loss: โ EPO, bili normal ยท hemolysis: โ bili
- Hp โ hemolysis/liver dz ยท โ acute phase
- EPO โ renal/hypothyroid ยท โ PRCA/tumors
Confusing Pairs
- Erythron โ RBC mass
- Polychromasia โ basophilic stippling
- Hp (Hb dimers, ฮฑ2) โ hemopexin (heme, ฮฒ)
- Hemoglobinuria (acute) โ hemosiderinuria (delayed)
- BFU-E (CD34+) โ CFU-E (CD34โ)
Normal Variation
- Birth: Hb ~19, RBC 5.2
- 2โ3 months: Hb 10โ11 (physiologic)
- Men > women after puberty (testosterone)
- Altitude โ โ RBC, โ 2,3-BPG
- Egress: loss of fibronectin receptor
9 ยท Final Memory Map
- ๐ด ERYTHROCYTE PRODUCTION & DESTRUCTION
- Progenitors
- BFU-E: CD34+, IL-3/GM-CSF, few EPO-R
- CFU-E: max EPO-R, EPO-dependent
- 18โ21 days to RBC
- Precursors
- Pro (8:1, nucleoli) โ Baso (deeper blue) โ Poly (last mitosis, first Hb) โ Ortho (pyknotic, extrudes)
- Pyrenocyte eaten via PS ยท Howell-Jolly = fragments
- Erythroblastic island: central macrophage, fibronectin
- Reticulocyte
- 0.5โ2.5% ยท NMB stain ยท polychromasia on Wright
- Absolute = % ร RBC ยท shift retics under EPO
- Leaves marrow after losing adhesion receptors
- Erythropoietin
- Kidney peritubular cells ยท hypoxia ยท HIF-1
- Anti-apoptosis (Fas/FasL, Bcl-XL) = main action
- Faster maturation ยท early release
- โ in renal anemia
- Membrane
- Lipid asymmetry (flippase) ยท cholesterol exchange/LCAT
- Integral: band 3, glycophorins ยท Peripheral: spectrin, ankyrin, 4.1, 4.2
- Deformability: shape, viscosity, skeleton ยท Naโบ/Kโบ pump
- Metabolism
- EMP โ ATP (PK)
- HMP โ NADPH (G6PD) โ Heinz bodies if deficient
- MetHb reductase โ NADH โ Feยฒโบ
- R-L shunt โ 2,3-BPG โ Oโ release
- Destruction
- Senescence: enzymes decay โ sphere โ splenic trap
- Extravascular 90%: heme โ bilirubin, iron recycled
- Intravascular 10%: Hp โ hemopexin โ methemalbumin; hemoglobinuria, hemosiderinuria
- Progenitors